Pfizer company outlook: a "Covid-19 dependent" business?

Detalhes bibliográficos
Autor(a) principal: Arias, David
Data de Publicação: 2022
Tipo de documento: Dissertação
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10362/148071
Resumo: This equity report aims at analyzing and evaluating the pharmaceutical company Pfizer in a context of the global pandemic and the possible outcomes of the post-pandemic. We also researched the latest industry trends and analyzed the pharma regulation, M&A activity, patents, and emerging technologies. Thorough the report, we explained the methodologies and how recent industry and economic factors will affect the revenues of the main Pfizer’s pharmaceutical products
id RCAP_8b50fce41e02ee4e3f3987ae9379205d
oai_identifier_str oai:run.unl.pt:10362/148071
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Pfizer company outlook: a "Covid-19 dependent" business?ValuationInnovationR&DHealthcareCovidVaccinesPatentsOncologyDomínio/Área Científica::Ciências Sociais::Economia e GestãoThis equity report aims at analyzing and evaluating the pharmaceutical company Pfizer in a context of the global pandemic and the possible outcomes of the post-pandemic. We also researched the latest industry trends and analyzed the pharma regulation, M&A activity, patents, and emerging technologies. Thorough the report, we explained the methodologies and how recent industry and economic factors will affect the revenues of the main Pfizer’s pharmaceutical productsAntunes, FranciscoRUNArias, David2023-01-24T17:03:30Z2022-06-072022-05-192022-06-07T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfhttp://hdl.handle.net/10362/148071TID:203136055enginfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-03-11T05:29:26Zoai:run.unl.pt:10362/148071Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T03:53:11.574325Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Pfizer company outlook: a "Covid-19 dependent" business?
title Pfizer company outlook: a "Covid-19 dependent" business?
spellingShingle Pfizer company outlook: a "Covid-19 dependent" business?
Arias, David
Valuation
Innovation
R&D
Healthcare
Covid
Vaccines
Patents
Oncology
Domínio/Área Científica::Ciências Sociais::Economia e Gestão
title_short Pfizer company outlook: a "Covid-19 dependent" business?
title_full Pfizer company outlook: a "Covid-19 dependent" business?
title_fullStr Pfizer company outlook: a "Covid-19 dependent" business?
title_full_unstemmed Pfizer company outlook: a "Covid-19 dependent" business?
title_sort Pfizer company outlook: a "Covid-19 dependent" business?
author Arias, David
author_facet Arias, David
author_role author
dc.contributor.none.fl_str_mv Antunes, Francisco
RUN
dc.contributor.author.fl_str_mv Arias, David
dc.subject.por.fl_str_mv Valuation
Innovation
R&D
Healthcare
Covid
Vaccines
Patents
Oncology
Domínio/Área Científica::Ciências Sociais::Economia e Gestão
topic Valuation
Innovation
R&D
Healthcare
Covid
Vaccines
Patents
Oncology
Domínio/Área Científica::Ciências Sociais::Economia e Gestão
description This equity report aims at analyzing and evaluating the pharmaceutical company Pfizer in a context of the global pandemic and the possible outcomes of the post-pandemic. We also researched the latest industry trends and analyzed the pharma regulation, M&A activity, patents, and emerging technologies. Thorough the report, we explained the methodologies and how recent industry and economic factors will affect the revenues of the main Pfizer’s pharmaceutical products
publishDate 2022
dc.date.none.fl_str_mv 2022-06-07
2022-05-19
2022-06-07T00:00:00Z
2023-01-24T17:03:30Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10362/148071
TID:203136055
url http://hdl.handle.net/10362/148071
identifier_str_mv TID:203136055
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799138123047763968

Registros relacionados